Wayde D. McMillan
Known title: Chief Financial OfficerCIK: 0001768648
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Insulet Sets Q3 2026 Earnings Date for Nov 4. Insulet has scheduled its third-quarter 2026 financial results for release on November 4, 2026. Recent commentary suggests the company offers affordable growth supported by strong fundamentals. The stock is currently trading near its 52-week low, with technical indicators showing a support rejection and volume spike.
Transaction History
| SOLV | ▲ Buy | Option Exercise | 9,503 | $0 | 5/13/2026 | View on chart |
| SOLV | ▼ Sell | Tax Withholding | 4,404 | $328K | 5/13/2026 | View on chart |
| SOLV | ▼ Sell | Tax Withholding | 2,786 | $193K | 3/6/2026 | View on chart |
| SOLV | ▲ Buy | Option Exercise | 8,802 | $0 | 3/6/2026 | View on chart |
| SOLV | ▲ Buy | Option Exercise | 28,010 | — | 12/1/2025 | View on chart |
| SOLV | ▼ Sell | Tax Withholding | 12,980 | $1.1M | 12/1/2025 | View on chart |
| SOLV | ▲ Buy | Option Exercise | 9,502 | $0 | 5/13/2025 | View on chart |
| SOLV | ▼ Sell | Tax Withholding | 3,918 | $288K | 5/13/2025 | View on chart |
| SOLV | ▲ Buy | Option Exercise | 28,010 | $0 | 12/1/2024 | View on chart |
| SOLV | ▼ Sell | Tax Withholding | 11,112 | $795K | 12/1/2024 | View on chart |
| PODD | ▼ Sell | Open Market | 1,388 | $393K | 7/3/2023 | View on chart |
| PODD | ▼ Sell | Open Market | 1,255 | $399K | 4/3/2023 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 350 | $97K | 2/28/2023 | View on chart |
| PODD | ▲ Buy | Grant | 2,713 | $0 | 2/28/2023 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 153 | $45K | 2/17/2023 | View on chart |
| PODD | ▲ Buy | Grant | 3,212 | $0 | 2/17/2023 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 1,092 | $323K | 2/17/2023 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 205 | $60K | 2/10/2023 | View on chart |
| PODD | ▼ Sell | Open Market | 1,359 | $389K | 1/3/2023 | View on chart |
| PODD | ▼ Sell | Open Market | 1,455 | $401K | 4/1/2022 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 3,134 | $817K | 3/1/2022 | View on chart |
| PODD | ▲ Buy | Grant | 2,361 | $0 | 2/28/2022 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 522 | $137K | 2/26/2022 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 2,673 | $626K | 2/18/2022 | View on chart |
| PODD | ▲ Buy | Grant | 7,057 | $0 | 2/18/2022 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 153 | $37K | 2/17/2022 | View on chart |
| PODD | ▼ Sell | Tax Withholding | 205 | $52K | 2/10/2022 | View on chart |
| PODD | ▼ Sell | Open Market | 672 | $182K | 12/31/2021 | View on chart |
| PODD | ▼ Sell | Open Market | 400 | $107K | 12/31/2021 | View on chart |
| PODD | ▼ Sell | Open Market | 193 | $51K | 12/31/2021 | View on chart |
| PODD | ▼ Sell | Open Market | 500 | $134K | 12/31/2021 | View on chart |
| PODD | ▼ Sell | Open Market | 90 | $24K | 12/31/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 4, 2026
Solventum Featured in Yahoo’s Overrated and Profitable Stock Lists
Yahoo highlighted Solventum in two recent articles. In one piece it was listed among stocks that may be overvalued, while the other article named it a profitable long‑term option. The coverage may influence how investors view the company’s valuation and growth prospects. The stock remains near the middle of its 52‑week range.
Solventum Featured in Yahoo’s Overrated and Profitable Stock Lists. Yahoo highlighted Solventum in two recent articles. In one piece it was listed among stocks that may be overvalued, while the other article named it a profitable long‑term option. The coverage may influence how investors view the company’s valuation and growth prospects. The stock remains near the middle of its 52‑week range.